TECH UNIVERSITY BIOTECH 101 STEALABLE SLIDES

The following slides are stealable. Please use them however you like! Technology and Innovation Initiative The following slides are stealable. Please use them however you like!

A New World: Applications of Biotechnology Biotechnology has been active in the pharmaceutical and medical industries longer than it has been part of any other entity e.g. penicillin and other antibiotics are synthesized through biotechnological processes. Enzymes are used in the brewing process for making beer and other alcoholic beverages. As the beer industry continues to grow and thrive, these biotechnological techniques will be implemented more and more. DNA, the genetic code of all living things, can be edited with biotechnology. Genome editing is a new technology that allows scientists to manipulate genetic information. In the future, this type of gene therapy could be used for cancer prevention and treatment. Fruits, vegetables, and other consumable agricultural products can be genetically modified through biotechnology. Transgenic plant technology was the starting point for the same type of genome-editing biotechnology that is being researched on human somatic cells..

Top Asia-Pacific venture financings (biotechnology sector, 2016) Company Country Capital Innovent Biologics China $260M Cstone Pharmaceuticals $150M Zai Lab $100M Harbour BioMed $50M JW CreaGene $43M CARsgen Therapeutics South Korea $30M Adagene $28M TenNor Therapeutics $25M Anhui Zhongsheng Suyuan $23M Jitsubo Japan Sources: BioCentury, Capital IQ, VentureSource

Industry and Investment China has lead in biotech-related agricultural developments since 2013 with the highest volume (42%) of research. China’s local and federal governments heavily fund biotechnology initiatives. Developing cities receive much of this investment. In the first quarter of 2018, China invested in US $1.4 billion worth of US biotechnology initiatives. China follows a policy system that allows for fast approval and implementation of biotechnology-focused clinical trials.

Top Asia-Pacific IPOs 2016, Biotech Company Country Capital BeiGene China $182MM Asymchem Laboratories $130MM SillaJen South Korea $129MMM Betta Pharmaceuticals $106MM Autobio Diagnostics $92MM Qurient $28MM PanGen Biotech $23MM Anterogen $14MM Anygen $11MM Sources: BioCentury, Capital IQ, VentureSource

China’s Investment (in millions of USD) US $200MM Raised by 16 biotechnology companies since the start of the 2010s US $737.1MM Projected total capital to be invested in biotechnology’s global market by 2025 US $2,790MM Spent by China on Research and Development of biotechnology in 2017

China：Industry Leader in Gene-Editing Number of articles studying the use of CRISPR systems in plant genome editing with agricultural applications  Sources: AgroParisTech

Thank you! Address: Floor 3, Gate 4, Pacific Century Place, 2A Workers' Stadium North Road,Chaoyang District, Beijing, 100027 地址：北京市朝阳区工体北路甲2号， 盈科中心4号门3层。 邮编100027 Tel: (8610) 8519-0800 | Fax: (8610) 8519-0899 | E-mail: amcham@amchamchina.org Website: www.amchamchina.org